½ÃÀ庸°í¼­
»óǰÄÚµå
1541062

¼¼°èÀÇ °æÀå ¿µ¾ç ±â±â ½ÃÀå º¸°í¼­ : Á¦Ç° À¯Çü, ¿¬·ÉÃþ, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº°(2024-2032³â)

Enteral Feeding Devices Market Report by Product Type, Age Group, Application, End User, and Region 2024-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 149 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ °æÀå ¿µ¾ç ±â±â ½ÃÀå ±Ô¸ð´Â 2023³â 40¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº ½ÃÀåÀÌ 2032³â±îÁö 66¾ï ´Þ·¯¿¡ À̸¦ Àü¸ÁÀÌ¸ç ¿¹Ãø ±â°£ µ¿¾È 5.6%ÀÇ º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù.

°æÀå ¿µ¾ç ±â±â´Â ¿µ¾ç Æ©ºê¸¦ ÅëÇØ ¼ÒÈ­°ü¿¡ Á÷Á¢ ¿µ¾çÀ» °ø±ÞÇÏ´Â µ¥ »ç¿ëµÇ´Â ´Ù¾çÇÑ µµ±¸ ¹× Àåºñ¸¦ ÀǹÌÇÕ´Ï´Ù. ÀÌ ±â¼úÀº ÁÖ·Î ½Äǰ, ¾×ü ¹× ¿µ¾ç º¸ÃæÁ¦ÀÇ °æ±¸ ¼·Ãë°¡ ¾î·Á¿î ȯÀÚ¿¡°Ô »ç¿ëµË´Ï´Ù. ÀϹÝÀûÀ¸·Î »ç¿ëµÇ´Â °æÀå ¿µ¾ç Àåºñ¿¡´Â ¿µ¾ç ÆßÇÁ, Æ©ºê, Åõ¿© ¼¼Æ®, °æÀå ÁÖ»ç±â, ¼Ò¸ðǰ µîÀÌ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â±¸´Â ´Ü¹éÁú, ź¼öÈ­¹°, Áö¹æ, ¼öºÐ, ¹Ì³×¶ö, ºñŸ¹ÎÀ» Æ÷ÇÔÇÑ ½ÄǰÀ» Áö¼ÓÀûÀ¸·Î Á¤È®ÇÏ°Ô °ø±ÞÇÒ ¼ö ÀÖ½À´Ï´Ù. Á¾·¡ºÎÅÍ »ç¿ëµÇ°í ÀÖ´Â Æú¸®¿°È­ºñ´ÒÁ¦ÀÇ °æ°ü¿¡ ºñÇØ, ½Ç¸®ÄÜÀÇ »õ·Î¿î °æ°üÀº À¯¿¬¼ºÀÌ ³ô°í, ¼ÒÈ­ È¿¼Ò¸¦ ¸¸Á®µµ ¿°ÁõÀ» ÀÏÀ¸Å°Áö ¾Ê½À´Ï´Ù.

´ç´¢º´, ¾Ï, À§Àå Áúȯ µî ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. °Ô´Ù°¡ ÀÌ¿Í °°Àº ÀÇ·áÀû Áúȯ¿¡ °É¸®±â ½¬¿î ³ëÀÎ Àα¸°¡ Áõ°¡Çϰí ÀÖ´Â °Íµµ ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ´Ù¹ß¼º °æÈ­Áõ, ³úÁ¹Áß, Ä¡¸Å µîÀÇ Áúº´°ú ½Å°æ Áõ»óÀº ȯÀÚÀÇ »ïŰ´Â ´É·Â¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ¿µ¾ç ºÒ·®À» À¯¹ßÇÕ´Ï´Ù. ÀÌ·Î ÀÎÇØ °æ±¸ º¸ÃæÁ¦¿Í ¿µ¾ç Æ©ºê¸¦ ÅëÇØ ¿µ¾ç º¸ÃæÀ» Áö¿øÇÒ ¼öÀÖ´Â °æ°æÀå ¿µ¾ç ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ÀçÅðæÀ念¾çÀÇ µîÀåµµ ½ÃÀå¿¡ ¹àÀº Àü¸ÁÀ» °¡Á®¿À°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼Ò¾Æ ȯÀÚ¿Í ¼ºÀΠȯÀÚ ¸ðµÎ¿¡ ÀûÇÕÇÑ ¾ãÀº À§·ç ¹öưÀÇ °³¹ß°ú °°Àº ´Ù¾çÇÑ ±â¼úÀû Áøº¸°¡ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ±âŸ¿¡µµ ÀÇ·á ÀÎÇÁ¶óÀÇ °³¼±À̳ª ½Å»ý¾Æ,Á¶»ê¾Æ¿ë °æÀå ¿µ¾ç ±â±â ¼ö¿ä Áõ°¡ µîÀÌ ½ÃÀåÀ» ´õ¿í °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®

  • ¼¼°èÀÇ °æÀå ¿µ¾ç ±â±â ½ÃÀåÀº Áö±Ý±îÁö ¾î¶»°Ô ÃßÀÌÇϰí ÇâÈÄ ¾î¶»°Ô ÃßÀÌÇÒ °ÍÀΰ¡?
  • COVID-19´Â ¼¼°èÀÇ °æÀå ¿µ¾ç ±â±â ½ÃÀå¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÃÆ´Â°¡?
  • ÁÖ¿ä Áö¿ª ½ÃÀåÀº?
  • Á¦Ç° À¯Çüº° ½ÃÀå ºÐ¼®Àº?
  • ¿¬·ÉÃþº° ½ÃÀå ºÐ¼®Àº?
  • ¿ëµµº° ½ÃÀå ºÐ¼®Àº?
  • ÃÖÁ¾ »ç¿ëÀÚº° ½ÃÀå ºÐ¼®Àº?
  • ¾÷°èÀÇ ¹ë·ùüÀÎÀÇ ´Ù¾çÇÑ ´Ü°è¶õ?
  • ¾÷°èÀÇ ÁÖ¿ä ÃËÁø¿äÀΰú µµÀüÀº ¹«¾ùÀΰ¡?
  • ¼¼°èÀÇ °æÀå ¿µ¾ç ±â±â ½ÃÀåÀÇ ±¸Á¶¿Í ÁÖ¿ä ÁøÃâ±â¾÷Àº?
  • ¾÷°è °æÀïµµ´Â?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • Á¶»çÀÇ ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ Á¤º¸
    • 2Â÷ Á¤º¸
  • ½ÃÀå ÃßÁ¤
    • »óÇâ½Ä Á¢±Ù
    • ÇÏÇâ½Ä Á¢±Ù
  • Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼Ò°³

  • °³¿ä
  • ÁÖ¿ä ¾÷°è µ¿Çâ

Á¦5Àå ¼¼°èÀÇ °æÀå ¿µ¾ç ±â±â ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå ½ÇÀû
  • COVID-19ÀÇ ¿µÇâ
  • ½ÃÀå ¿¹Ãø

Á¦6Àå ½ÃÀå ³»¿ª : Á¦Ç° À¯Çüº°

  • °æÀå ¿µ¾ç ÆßÇÁ
  • °æÀå ¿µ¾ç Æ©ºê
  • ¼±¹° ¼¼Æ®
  • °æÀå ÁÖ»ç±â
  • ¼Ò¸ðǰ
  • ±âŸ

Á¦7Àå ½ÃÀå ºÐ¼® : ¿¬·ÉÃþº°

  • ¼ºÀÎ
  • ¼Ò¾Æ

Á¦8Àå ½ÃÀå ºÐ¼® : ¿ëµµº°

  • Á¾¾çÇÐ
  • ¼ÒÈ­±â ³»°ú
  • ½Å°æÇÐ
  • ´ç´¢º´
  • ´ë»ç Ç×Áø
  • ±âŸ

Á¦9Àå ½ÃÀå ³»¿ª : ÃÖÁ¾ »ç¿ëÀÚº°

  • º´¿ø
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • ±âŸ

Á¦10Àå ½ÃÀå ºÐ¼® : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • Àεµ³×½Ã¾Æ
    • ±âŸ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ºÐ¼® : ±¹°¡º°
    • ½ÃÀå ¿¹Ãø

Á¦11Àå SWOT ºÐ¼®

  • °³¿ä
  • °­Á¡
  • ¾àÁ¡
  • ±âȸ
  • À§Çù

Á¦12Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦13Àå Porter's Five Forces ºÐ¼®

  • °³¿ä
  • ±¸¸ÅÀÚÀÇ Çù»ó·Â
  • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
  • °æÀïµµ
  • ½Å±Ô Âü°¡¾÷üÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù

Á¦14Àå °¡°Ý ºÐ¼®

Á¦15Àå °æÀï ±¸µµ

  • ½ÃÀå ±¸Á¶
  • ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Abbott Laboratories
    • Amsino International Inc.
    • B. Braun Melsungen Aktiengesellschaft(B. Braun Holding GmbH & Co. KG)
    • BD(Becton Dickinson and Company)
    • Boston Scientific Corporation
    • Cardinal Health Inc.
    • Commed Corporation
    • Fresenius Kabi Aktiengesellschaft(Fresenius SE & Co. KGaA)
    • Moog Inc.
BJH 24.09.12

The global enteral feeding devices market size reached US$ 4.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.6 Billion by 2032, exhibiting a growth rate (CAGR) of 5.6% during 2024-2032.

Enteral feeding devices refer to various tools and equipment used for the delivery of nutrients directly into the digestive tract through a feeding tube. This technique is primarily used for patients experiencing difficulties in the oral intake of food products, liquids and nutritional supplements. Some of the commonly used enteral feeding devices include feeding pumps, tubes, giving sets, enteral syringes and consumables. These devices enable consistent and accurate delivery of food containing proteins, carbohydrates, fats, water, minerals and vitamins. In comparison to the traditionally used polyvinylchloride feeding tubes, novel silicon-based variants are more flexible and do not cause irritation upon exposure to digestive enzymes.

The increasing prevalence of chronic diseases, such as diabetes, cancer and gastrointestinal ailments, is one of the key factors driving the growth of the market. Furthermore, the rising geriatric population that is more susceptible to such medical illnesses is driving the market growth. Diseases and neurological conditions, such as multiple sclerosis, stroke and dementia, impact the patient's ability to swallow and cause malnourishment. This has enhanced the demand for enteral feeding devices that can aid in providing nutritional support through oral supplements and feeding tubes. In line with this, the advent of home enteral nutrition is also creating a positive outlook for the market. Additionally, various technological advancements, such as the development of low-profile gastrostomy buttons that are suitable for both children and adult patients, are contributing to the market growth. Other factors, including improving healthcare infrastructure, along with the growing demand for neonatal and preterm enteral feeding devices, are expected to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global enteral feeding devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product type, age group, application and end user.

Breakup by Product Type:

Enteral Feeding Pumps

Enteral Feeding Tubes

Giving Sets

Enteral Syringes

Consumables

Others

Breakup by Age Group:

Adults

Pediatrics

Breakup by Application:

Oncology

Gastroenterology

Neurology

Diabetes

Hypermetabolism

Others

Breakup by End User:

Hospitals

Ambulatory Surgery Centers

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Amsino International Inc., B. Braun Melsungen Aktiengesellschaft (B. Braun Holding GmbH & Co. KG), BD (Becton Dickinson and Company), Boston Scientific Corporation, Cardinal Health Inc., Conmed Corporation, Fresenius Kabi Aktiengesellschaft (Fresenius SE & Co. KGaA) and Moog Inc.

Key Questions Answered in This Report:

  • How has the global enteral feeding devices market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global enteral feeding devices market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the age group?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global enteral feeding devices market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Enteral Feeding Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Enteral Feeding Pumps
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Enteral Feeding Tubes
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Giving Sets
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Enteral Syringes
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Consumables
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Age Group

  • 7.1 Adults
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Pediatrics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Oncology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Gastroenterology
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Neurology
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Diabetes
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Hypermetabolism
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Ambulatory Surgery Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Amsino International Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 B. Braun Melsungen Aktiengesellschaft (B. Braun Holding GmbH & Co. KG)
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 BD (Becton Dickinson and Company)
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Boston Scientific Corporation
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Cardinal Health Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Conmed Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Fresenius Kabi Aktiengesellschaft (Fresenius SE & Co. KGaA)
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 SWOT Analysis
    • 15.3.9 Moog Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦